Events

Tyler Bartholomew, PhD, is an Assistant Professor in the Division of Health Services Research & Policy at the University of Miami Miller School of Medicine’s Department of Public Health Sciences. He is the co-Principal Investigator of the UM IDEA Lab whose mission is to implement, disseminate, educate, and advocate for the health of people who use drugs. His research has focused on developing, testing, and implementing interventions to address the substance use and infectious disease syndemic, leveraging data-driven approaches to improve health services, systems, and policy implementation for this population. Dr. Bartholomew led the research and evaluation efforts of the IDEA Miami Syringe Services Program (SSP), the first legal syringe services program in Florida. His research and advocacy efforts translated into statewide legislation allowing all counties in Florida to implement these evidence-based programs in 2019.

His research has been funded by the National Institutes of Health, the Centers for Disease Control and Prevention, and Gilead Sciences and has resulted in over 60 publications in high impact journals including: American Journal of Public Health, Clinical Infectious Diseases, Addiction, and International Journal of Drug Policy. He currently leads 3 NIDA-funded trials investigating the effectiveness of a peer-driven, telehealth-enhanced model of care for HIV treatment, PrEP and medications for opioid use disorder among people who inject drugs and a national implementation science trial of routine point-of-care HIV and hepatitis C testing at syringe services programs. He is an investigator in the Clinical Trials Network Florida Node Alliance funded by the National Institute on Drug Abuse. He currently supports statewide implementation of SSPs in Florida through a partnership with the Florida Harm Reduction Collective where they leverage community-driven implementation science to improve adoption, implementation, and sustainment of programs. Dr. Bartholomew received his PhD in Prevention Science from the University of Miami.

LINK TO VIDEO

José Diaz, PhD

Examining the Impact of Intersectional Stigma and Resilience on Substance Use Treatment Utilization Among Latinx Men Who Have Sex With Men

Mentors: Dustin Duncan, Sabina Hirshfield, and Carlos Rodriguez-Diaz

Justin Knox, PhD

Formative Research on How to Deliver Alcohol Interventions in the Context of HIV Prevention and Care among Black Sexual Minority Men

Mentors: Dustin Duncan, Elvin Geng, John Schneider, Donna Shelley, and Scott Sherman

Cho-Hee Shrader, PhD, MPH

Feasibility of a Sociocentric Network-based Respondent Driven Sampling Recruitment Method for HIV Prevention Programming among Black, Latino, and Caribbean Men Who Have Sex With Men and Use Drugs: A Multilevel Implementation Science Study

Mentors: Dustin Duncan and Danielle Ompad

LINK TO VIDEO

In collaboration with Don Des Jarlais and his team, Dr. Bobashev developed an agent-based model (ABM) that describes the transmission of HIV in a population of people who inject drugs in NYC and Vietnam. They show that under general assumptions the transmission rate is very low, but small outbreaks are possible in tightly connected communities. Dr. Bobashev will discuss how ABMs can provide insight into disease transmission in complex systems where many factors are at play. Conducting multiple simulations allows us to focus not only on the means or most likely scenarios but at some rare but extreme cases leading to notable outbreaks.

Georgiy Bobashev is a Senior Fellow at RTI International with more than 20 years of experience in health research. His current research interests follow two major areas: predictive modeling and studies of substance use and risky behaviors. Predictive methods often combine mechanistic (e.g., agent-based and system dynamics) and machine learning techniques. Dr. Bobashev has applied modeling, statistical analysis and experimental design to a variety of health- and policy-related areas, including substance use, HIV, child/maternal health, influenza, cancer, diabetes, and violent behavior. He has been a principal investigator and co-investigator on numerous grants from the National Institutes of Health (NIH).

In addition to his RTI duties, Dr. Bobashev is an adjunct Professor at the Department of Statistics at North Carolina State University, adjunct Professor at the NYU School of Global Public Health, and a Professor at the Data Science Tech Institute in Sofia Antipolis, France.

LINK TO VIDEO

Shruti Mehta is a Professor and Chair of the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She received a Master’s in Public Health (1997) and a PhD (2002) in Epidemiology also from the Johns Hopkins Bloomberg School of Public Health. Her research focuses on HIV and hepatitis C virus (HCV) infection among people who inject drugs (PWID) in the US and in India with a particular interest and focus on identifying and overcoming barriers to access care and treatment for HIV and HCV.

Dr. Mehta has led research programs in Baltimore and India that have produced more than 350 peer-reviewed papers. She has been continuously funded for more than 20 years with grants from the National Institutes of Health, the Patient-Centered Outcomes Research Institute (PCORI), the President’s Emergency Plan for AIDS Relief (PEPFAR), the U.S. Agency for International Development, and the National Science Foundation.

LINK TO VIDEO

Photovoice is a participatory, qualitative research approach where participants use photography and stories about their photos to identify and represent issues of importance to them enabling researchers to gain a greater understanding of the topic under study. Dr. Walters will present the theoretical origins and practical applications of the method using examples of their respective research studies among individuals in marginalized communities including those who use drugs and are affected by HIV.

Suzan Walters is an Assistant Professor in the Division of Epidemiology in the Department of Population Health at the NYU Grossman School of Medicine and an affiliated researcher at the Center for Drug Use and HIV/HCV Research (CDUHR) at New York University. Her mixed-methods research focuses on the social and structural determinants of health among drug using populations. Her current K01 grant focuses on how intersectional stigma experiences affect health outcomes among people who use drugs. Dr. Walter’s current CDUHR-funded pilot study is exploring barriers and facilitators to PrEP, harm reduction, and use of Overdose Prevention Centers using Photovoice, a community-based, participatory research methodology.

LINK TO VIDEO

This talk will explore the social and structural factors contributing to racial inequities in HIV. Additionally, it will highlight effective structural interventions aimed at reducing these disparities.

Natalie Crawford is an Associate Professor in Behavioral, Social and Health Education Sciences in the Rollins School of Public Health at Emory University. She serves as the Co-Director of the Prevention and Implementation Sciences Core in the Center for AIDS Research at Emory. Trained in social epidemiology, she received her PhD and MPH in Epidemiology from Columbia University’s Mailman School of Public Health. Dr. Crawford completed her post-doctoral training at the University of Michigan as a Robert Wood Johnson Health and Society Scholar. She graduated from Spelman College where she trained in Women Studies and Biochemistry. Her NIMH-supported research examines the impact of structural interventions in pharmacies on reducing racial inequities in HIV. She is currently advancing the implementation science of HIV prevention services in pharmacies in the US Southeast.

Link to Video

Foresight research helps us consider various future scenarios and how to prepare for them. This is crucial in drug policy where decisions can significantly impact society and people who use drugs. In his presentation, Tuukka Tammi will explore strategic foresight as a method that has so far been underutilized in social sciences and discuss its relevance for drug policy research, the tools it employs, and its practical applications. He will also share key findings from a recent study examining Finland’s drug policy trajectory toward 2030.

For further reading, the article on which the presentation is based: Unlu, A, Viskari, I, Rönkä, S, & Tammi, T (2024). Developing strategic foresight for drug policy: trends, scenarios, and implications. Drugs: Education, Prevention and Policy, 1–16. doi: 10.1080/09687637.2024.2331574

Tuukka Tammi, PhD, is a Lead Expert at the Finnish Institute for Health and Welfare (THL). His research interests are related to public and social policy analysis, health and social care system research and development, research into social problems, especially addiction research, as well as strategic foresight. Tuukka Tammi is also an associate professor (title of docent) at the Universities of Helsinki and Tampere.

Link to Video

Dương Thị Hương is Associate Professor, Senior Lecturer, and Formal Dean of Faculty of Public Health at the Hai Phong University of Medicine and Pharmacy. Dr. Huong has had numerous projects funded by the French National Research Agency for AIDS Research (ANRS) and the National Institute on Drug Abuse focused on HIV, HCV, and related infections in people who inject drugs (PWID).

Drug Use & Infections in Vietnam (DRIVE) aimed to end the HIV epidemic among people who inject drugs in Hai Phong, Vietnam (NIDA R01DA041978/ANRS 12353) and ran from 2016 to 2021. DRIVE has been a foundation for several subsequent initiatives, including DRIVE-C (Drug Use & Infections in Vietnam – Hepatitis C) (ANRS 12380), which focused on HCV elimination; DRIVE-MIND Mental Health Intervention for Injecting Drug Users, (ANRS 12410); DRIVE-COVID (ANRS COV22), which evaluated the impact of lockdown measures on HIV and HCV risk behaviors and access to prevention and care during the COVID-19 epidemic for PWID in Hai Phong; and DRIVE-TB Tuberculosis Control, (ANRS 0092, co-funded by NIDA, ANRS|MIE, and L’initiative-Expertise France), aimed at tuberculosis elimination among PWIDs. These projects have resulted in publications in over 20 international journals. The Community HIV Epidemiological Evaluation and Response (CHEER) program has utilized the DRIVE model to evaluate the HIV epidemic in other provinces.